Medical tracer technologies are routinely used to detect cancer, but emerging nanotechnologies have the ability to treat as well as trace. What do we need to do to accelerate their adoption?
Medical tracer technologies are routinely used to detect cancer, but emerging nanotechnologies have the ability to treat as well as trace. What do we need to do to accelerate their adoption?
